TBG Diagnostics (Australia) Profile

0.16

AUD

0.00

0.00%

0.16

0.16

TBG Diagnostics Stories on August 21, 2018

TBG Diagnostics Limited Risk Profiles

Mean Deviation	5.71
Standard Deviation	9.41
Variance	88.64
Risk Adjusted Performance	0.041562

Key Fundamentals

Current Valuation	9.63 M
Shares Outstanding	124.86 M
Revenue	3.44 M

More Fundamentals

TBG Diagnostics Against Markets

DOW	0.35 %	0%	39.0%	DOW Profile DOW Dashboard DOW Technical analysis Backtest DOW
PGL	0.00 %	0%	0%	TBG Diagnostics Profile TBG Diagnostics Dashboard
All Or	0.89 %	100.0%	0%	All Ords Profile All Ords Dashboard

Compare to Competition

Compare Correlations

PGL

Diagnostics

TBG Diagnostics Limited, a biotechnology company, focuses on the development, manufacture, and marketing of nucleic acid test kits. more

Name	TBG Diagnostics Limited
CEO - Pharmasynth	Leslie Tillack View All
Macroaxis Advice	Not RatedUnknown Value
Instrument	Australia Stock View All
Business Address	Darra, QLD
Exchange	Australian Securities Exchange
Benchmark	DOW
Website	www.tbgbio.com
Phone	61 7 3273 9133
Currency	AUD - Australian Dollar

Other Suggestions

View Currently Related Equities

BHP Billiton Rio Tinto Commonwealth Bank Westpac Banking CSL Australia Wesfarmers Woolworths Group Woodside Petroleum Transurban American Airlines Alcoa Apple Best Buy Citigroup

Risk & Return

Correlation

Directors

TBG Diagnostics Corporate Directors

Fleur Lankesheer Director - Business Development and Legal
Keith Dredge Director of Drug Development
YuZen Cheng Director

Additionally take a look at Your Equity Center. Please also try Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.